Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Cancer Treatment Reviews|October 1, 1993
The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere)R Pazdur, A P Kudelka, J J Kavanagh, et al.
Cancer|February 15, 1993
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinomaR Pazdur, J A Ajani, Y Z Patt, et al.
Clinical Pharmacology and Therapeutics|September 13, 2016
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung CancerG K Raju, K Gurumurthi, R Domike, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
Colorectal cancer: chemotherapy treatment overviewM E Royce, D Medgyesy, T H Zukowski, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activityR Pazdur, A H Rossof, G Chandra, et al.
The Cancer Journal From Scientific American|August 5, 1998
Phase II study of Taxol in patients with advanced gastric carcinomaJ A Ajani, J Fairweather, P Dumas, et al.
The American Journal of Medicine|June 1, 1995
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosisZ Estrov, M Talpaz, G Mavligit, et al.
Investigational New Drugs|April 1, 1992
Phase II trial of fazarabine in advanced colorectal carcinomaK P Hubbard, K Daugherty, J A Ajani, et al.
Journal of the National Cancer Institute|July 20, 1994
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagusJ A Ajani, D H Ilson, K Daugherty, et al.
Cancer|March 10, 2001
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumorsP Kozuch, P M Hoff, K Hess, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reviews|October 1, 1993
The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere)R Pazdur, A P Kudelka, J J Kavanagh, et al.
Cancer|February 15, 1993
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinomaR Pazdur, J A Ajani, Y Z Patt, et al.
Clinical Pharmacology and Therapeutics|September 13, 2016
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung CancerG K Raju, K Gurumurthi, R Domike, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
Colorectal cancer: chemotherapy treatment overviewM E Royce, D Medgyesy, T H Zukowski, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activityR Pazdur, A H Rossof, G Chandra, et al.
The Cancer Journal From Scientific American|August 5, 1998
Phase II study of Taxol in patients with advanced gastric carcinomaJ A Ajani, J Fairweather, P Dumas, et al.
The American Journal of Medicine|June 1, 1995
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosisZ Estrov, M Talpaz, G Mavligit, et al.
Investigational New Drugs|April 1, 1992
Phase II trial of fazarabine in advanced colorectal carcinomaK P Hubbard, K Daugherty, J A Ajani, et al.
Journal of the National Cancer Institute|July 20, 1994
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagusJ A Ajani, D H Ilson, K Daugherty, et al.
Cancer|March 10, 2001
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumorsP Kozuch, P M Hoff, K Hess, et al.
Pageof 16